RecruitingObservationalLast updated Aug 11, 2026

Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus Photographs

Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus Photograph

Overview

ClinicalTrials.gov ID: NCT07758569
Lead Sponsor: Democritus University of ThraceOTHER
Brief Summary: Primary Objective

To validate the artificial intelligence subsystem of the DDART medical device for the automated detection of lesions compatible with glaucoma in a random sample of retinal fundus photographs.
Study Type: Observational

Status

Overall Status: Recruiting
Start Date: Apr 21, 2026Actual
Primary Completion Date: Apr 19, 2027Estimated
Completion Date: Apr 19, 2027Estimated

Study Record Dates

First Submitted: Aug 6, 2026
First Submitted that Met QC Criteria: Aug 6, 2026
First Posted: Aug 11, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 6, 2026
Last Update Posted: Aug 11, 2026Actual
Last Verified: Apr 2026

NCT07758582Recruiting

Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Diabetic Retinopathy in a Random Sample of Retinal Fundus Photographs

NCT06879834Recruiting

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

NCT04132401Completed

AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care

NCT07497815Not yet recruiting

Artificial Intelligence-assisted Diagnosis in Ophthalmology

NCT04774822Completed

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

NCT07222293Recruiting

Assessment of AI Program 'DRISTi' as a Screening Tool